Literature DB >> 5803303

Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro.

P H Stern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5803303

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  31 in total

1.  Effect of sex steroids on bone collagen synthesis in vitro.

Authors:  E Canalis; L G Raisz
Journal:  Calcif Tissue Res       Date:  1978-05-26

2.  Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments.

Authors:  T J Hahn; L R Halstead
Journal:  Calcif Tissue Int       Date:  1979-11-26       Impact factor: 4.333

3.  Serum blocks the osteolytic effect of cortisol in neonatal mouse calvaria.

Authors:  C Lowe; D H Gray; I R Reid
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

4.  Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones.

Authors:  P Lakatos; P H Stern
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

5.  Effects of vitamin D3 metabolites on bone cell calcium transport.

Authors:  R Dziak
Journal:  Calcif Tissue Res       Date:  1978-11-10

6.  The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria.

Authors:  I R Reid; J M Katz; H K Ibbertson; D H Gray
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

7.  Altered parathyroid hormone- or calcitonin-stimulated adenosine 3', 5'-monophosphate release by isolated perfused bone from glucocorticoid-treated rats.

Authors:  T Sugimoto; M Fukase; M Tsutsumi; T Tsunenari; T Fujita
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

Review 8.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.